EG23557A - Process for preparing aripiprazole - Google Patents

Process for preparing aripiprazole

Info

Publication number
EG23557A
EG23557A EG2004010004A EG2004010004A EG23557A EG 23557 A EG23557 A EG 23557A EG 2004010004 A EG2004010004 A EG 2004010004A EG 2004010004 A EG2004010004 A EG 2004010004A EG 23557 A EG23557 A EG 23557A
Authority
EG
Egypt
Prior art keywords
preparing aripiprazole
aripiprazole
preparing
Prior art date
Application number
EG2004010004A
Other languages
English (en)
Inventor
Hisayuki Tsujimori
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32652780&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG23557(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of EG23557A publication Critical patent/EG23557A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
EG2004010004A 2003-01-09 2004-01-05 Process for preparing aripiprazole EG23557A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003002996 2003-01-09

Publications (1)

Publication Number Publication Date
EG23557A true EG23557A (en) 2006-06-05

Family

ID=32652780

Family Applications (1)

Application Number Title Priority Date Filing Date
EG2004010004A EG23557A (en) 2003-01-09 2004-01-05 Process for preparing aripiprazole

Country Status (19)

Country Link
US (1) US6995264B2 (fr)
EP (1) EP1480953B2 (fr)
JP (2) JP5797090B2 (fr)
KR (1) KR100583667B1 (fr)
CN (1) CN1263742C (fr)
AR (1) AR042702A1 (fr)
AT (1) ATE308524T1 (fr)
AU (1) AU2003288755C1 (fr)
BR (2) BR0305500A (fr)
CA (1) CA2676216A1 (fr)
DE (1) DE60302139T3 (fr)
DK (1) DK1480953T4 (fr)
EG (1) EG23557A (fr)
ES (1) ES2250919T5 (fr)
MX (1) MXPA04002519A (fr)
MY (1) MY129831A (fr)
SI (1) SI1480953T2 (fr)
TW (1) TWI258470B (fr)
WO (1) WO2004063162A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1613598E (pt) * 2003-12-16 2012-01-13 Teva Pharma Métodos para preparar formas cristalinas de aripiprazol
US7714129B2 (en) * 2003-12-16 2010-05-11 Teva Pharmaceutical Industries Ltd. Methods of preparing anhydrous aripiprazole form II
WO2005077904A1 (fr) * 2004-02-05 2005-08-25 Teva Pharmaceutical Industries, Ltd. Procede d'elaboration d'aripiprazole
US7507823B2 (en) 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
KR101041551B1 (ko) * 2004-10-08 2011-06-15 수벤 라이프 사이언시스 리미티드 아리피프라졸 제조를 위해 유용한 신규 중간체와 신규중간체 및 아리피프라졸 제조 방법
US20060079689A1 (en) * 2004-10-12 2006-04-13 Vladimir Naddaka Processes for preparing and purifying carbostyril compounds such as aripiprazole and 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones
WO2006053781A1 (fr) * 2004-11-18 2006-05-26 Synthon B.V. Procédé de synthèse d'aripiprazole cristallin
CN1303068C (zh) * 2005-01-11 2007-03-07 中国人民解放军第二军医大学 一种阿立哌唑的制备方法
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
WO2007035348A2 (fr) * 2005-09-15 2007-03-29 Elan Pharma International, Limited Formulations aripiprazoliques nanoparticulaires
WO2007075871A2 (fr) * 2005-12-22 2007-07-05 Teva Pharmaceutical Industries Ltd. Procedes pour la reduction de la taille des particules d’aripiprazole
US20070149782A1 (en) * 2005-12-23 2007-06-28 Michael Brand Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of Aripiprazole
EP1845088B1 (fr) * 2006-04-10 2009-07-22 Ranbaxy Laboratories Limited Procédé amélioré pour la préparation d'aripipirazole
RU2497819C2 (ru) 2007-05-21 2013-11-10 Ривайва Фармасьютикалс, Инк. Композиции, синтез и способы применения атипичных нейролептиков на основе хинолина
EP2299814A4 (fr) 2008-05-27 2011-06-15 Reviva Pharmaceuticals Inc Compositions, synthèse et procédés d utilisation d agents antipsychotiques à base de pipérazine
CN101781246B (zh) * 2009-01-15 2012-02-29 成都康弘药业集团股份有限公司 一种合成阿立哌唑的改进方法
CN102413830A (zh) 2009-02-26 2012-04-11 雷维瓦药品公司 利用芳基哌嗪衍生物的组合物、合成及方法
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
WO2016181406A1 (fr) * 2015-05-08 2016-11-17 Davuluri Ramamohan Rao Procédé amélioré pour la préparation d'aripiprazole doté d'une taille de particule réduite

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
DE3034237A1 (de) † 1979-09-18 1981-04-16 Otsuka Pharmaceutical Co. Ltd., Tokyo Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2608788B2 (ja) * 1988-10-31 1997-05-14 大塚製薬 株式会社 精神分裂病治療剤
JP4060523B2 (ja) † 1999-11-24 2008-03-12 大塚製薬株式会社 カルボスチリル誘導体の製造法
AR033485A1 (es) † 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma

Also Published As

Publication number Publication date
EP1480953A1 (fr) 2004-12-01
HK1073110A1 (en) 2005-09-23
US6995264B2 (en) 2006-02-07
TWI258470B (en) 2006-07-21
AU2003288755C1 (en) 2015-02-19
CN1263742C (zh) 2006-07-12
ES2250919T5 (es) 2010-12-03
MY129831A (en) 2007-05-31
CN1590377A (zh) 2005-03-09
AR042702A1 (es) 2005-06-29
DK1480953T4 (da) 2010-11-15
SI1480953T1 (sl) 2006-04-30
JP2014148511A (ja) 2014-08-21
CA2676216A1 (fr) 2004-07-09
WO2004063162A1 (fr) 2004-07-29
DK1480953T3 (da) 2005-12-19
KR100583667B1 (ko) 2006-05-26
EP1480953B1 (fr) 2005-11-02
JP5797090B2 (ja) 2015-10-21
CA2458929C (fr) 2009-09-08
MXPA04002519A (es) 2005-04-04
US20040192915A1 (en) 2004-09-30
ES2250919T3 (es) 2006-04-16
CA2458929A1 (fr) 2004-07-09
AU2003288755B2 (en) 2005-08-25
BRPI0305500B1 (pt) 2018-01-23
SI1480953T2 (sl) 2010-12-31
EP1480953B2 (fr) 2010-08-18
BR0305500A (pt) 2004-11-03
DE60302139T2 (de) 2006-07-20
DE60302139D1 (de) 2005-12-08
ATE308524T1 (de) 2005-11-15
DE60302139T3 (de) 2011-02-24
KR20040093655A (ko) 2004-11-06
TW200418840A (en) 2004-10-01
JP2012031203A (ja) 2012-02-16
AU2003288755A1 (en) 2004-08-10

Similar Documents

Publication Publication Date Title
IL172331A0 (en) Processes for preparing 3-benzazepines
SI1480953T1 (sl) Postopek za pripravo aripiprazola
GB0306432D0 (en) Process
MY137678A (en) Process for preparing formaldehyde
SG137677A1 (en) Improved process for preparing polyalkenylsuccinimides
IL169879A0 (en) Process for preparing pyrrolotriazine derivatives
IL158016A (en) Method for preparing decorative elements
GB0303659D0 (en) Process
SI1575941T1 (sl) Postopek za pripravo (S)-pantoprazola
GB0304726D0 (en) New Process
IL172444A0 (en) Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative
EP1612213A4 (fr) Proc d de production de 2'-deoxy-2'-fluorouridine
IL177039A0 (en) Improved process for preparing rebamipide
GB0427450D0 (en) Process
GB0307259D0 (en) Process
IL175216A0 (en) Process for preparing methyllithium
IL175966A0 (en) Process for preparing aripiprazole
PL377822A1 (pl) Sposób sporządzania octanu metylo-2-difenylometylosulfinylu
IL183804A0 (en) Process for preparing substituted 2-alkoxycarbonyl-3-aminothiophenes
IL178069A0 (en) Process for preparing n-aryl-piperazine derivatives
GB0522075D0 (en) Process for preparing almodipline mesylate monohydrate
GB2412373B (en) Process for preparing guggulsterones
GB0325055D0 (en) New process
AU2003240491A8 (en) Process for preparing vinylaromatic compounds
GB0300733D0 (en) Process